BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yan XJ, Li WT, Chen X, Wang EM, Liu Q, Qiu HY, Cao ZJ, Chen SL. Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients. World J Gastroenterol 2015; 21(15): 4652-4659 [PMID: 25914475 DOI: 10.3748/wjg.v21.i15.4652]
URL: https://www.wjgnet.com/1007-9327/full/v21/i15/4652.htm
Number Citing Articles
1
Xiu‐Juan Yan, Qing‐Qing Luo, Hong‐Yi Qiu, Chen‐Feng Ji, Sheng‐Liang Chen. The impact of stigma on medication adherence in patients with functional dyspepsiaNeurogastroenterology & Motility 2021; 33(2) doi: 10.1111/nmo.13956
2
Ankur Segon, Yogita Segon, Vivek Kumar, Hirotaka Kato. A Qualitative Exploration to Understand Hospitalists’ Attitude Toward the Patient Experience Scoring SystemJournal of Patient Experience 2020; 7(6) doi: 10.1177/2374373520942418
3
Dinesh Krishna Narukulla, Venkata Rao Kaki. Sustainable synthesis of melitracen HCl and its key intermediate, 10,10-Dimethylanthrone: A green solvent-driven and economically efficient approach with comprehensive sustainability analysis using iGAL 2.0Journal of the Indian Chemical Society 2025; 102(11) doi: 10.1016/j.jics.2025.102067
4
Natthanan Poovipirom, Woraphat Ratta‐apha, Monthira Maneerattanaporn, Tanawat Geeratragool, Pritsana Chuenprapai, Somchai Leelakusolvong. Treatment outcomes in patients with globus: A randomized control trial of psychoeducation, neuromodulators, and proton pump inhibitorsNeurogastroenterology & Motility 2023; 35(3) doi: 10.1111/nmo.14500
5
Qian-Qian Wang, Li Cheng, Bi-Yu Wu, Ping Xu, Hong-Yi Qiu, Bo Wang, Xiu-Juan Yan, Sheng-Liang Chen. Short-course antidepressant therapy reduces discontinuation syndrome while maintaining treatment efficacy in patients with refractory functional dyspepsia: A randomized controlled trialFrontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.1063722
6
Xiu-Juan Yan, Hong-Yi Qiu, Qing-Qing Luo, Bo Wang, Ping Xu, Chen-Feng Ji, Sheng-Liang Chen. Improving Clinician-Patient Communication Alleviates Stigma in Patients With Functional Dyspepsia Receiving Antidepressant TreatmentJournal of Neurogastroenterology and Motility 2022; 28(1) doi: 10.5056/jnm20239
7
Naoko Masutani, Hisao Ogawa, Hirofumi Soejima, Sadanori Okada, Izuru Masuda, Masako Waki, Hideaki Jinnouchi, Yoshihiko Saito, Takeshi Morimoto. Long-Term Effects of Low-Dose Aspirin on Gastrointestinal Symptoms and Bleeding Complications in Patients with Type 2 DiabetesAmerican Journal of Cardiovascular Drugs 2025; 25(1) doi: 10.1007/s40256-024-00679-9
8
Hiroshi Mihara, Juntaro Matsuzaki, Takuya Okugawa, Tadayuki Oshima, Akihiro Asakawa, Takeshi Kamiya, Takaomi Kessoku, Hidekazu Suzuki, Ken Nakamura, Mariko Hojo, Hideki Mori, Takatsugu Yamamoto, Fumio Tanaka, Seiji Futagami, Ken Haruma, Takashi Joh, Motoyasu Kusano, Koji Yakabi. Methods to build and maintain effective clinician–patient relationships for adults with disorders of gut–brain interaction (DGBI): a systematic reviewJournal of Gastroenterology 2026;  doi: 10.1007/s00535-026-02467-5
9
Lifeng Qin, Jinmei Qin, Qian Yang, Xiaoping Lv, Liyi Huang. Efficacy and safety of pinaverium bromide combined with flupentixol-melitracen for diarrhea-type irritable bowel syndromeMedicine 2019; 98(2) doi: 10.1097/MD.0000000000014064
10
Brian E. Lacy. Review article: an analysis of safety profiles of treatments for diarrhoea‐predominant irritable bowel syndromeAlimentary Pharmacology & Therapeutics 2018; 48(8) doi: 10.1111/apt.14948
11
S Kindt, J Arts, P Caenepeel, F de Clerck, H De Schepper, H Louis, P Latour, T Mahler, S Nullens, H Piessevaux, K Routhiaux, J Schol, M Surmont, H Vafa, C Van de Bruaene, K Van Malderen, T Vanuytsel, L Wauters, F Wuestenberghs, J Tack. Belgian consensus on the management of patients with functional dyspepsiaActa Gastro Enterologica Belgica 2025; 88(2) doi: 10.51821/88.1.14136
12
Qian Huang, Shaopeng Zheng, Ting Cai, Suxin Zhang, Qian Su, Fen Wang. Factors associated with mood disorders and the efficacy of the targeted treatment of functional dyspepsia: A randomized clinical trialFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.859661